RxDoctor Payments DataLook up a doctor →

Daniel Carducci

Medical · Flemington, NJNPI 1669812731

Payments from drug & device makers

$9,316in general payments, 2019–2025

Across 674 payments — averaging $13.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$1K
  • AstraZeneca$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$854
  • Lilly USA, LLC$613
  • Pfizer$318
  • plus $4K from 45 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk132$1,738
AbbVie103$1,123
AstraZeneca54$1,106
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC80$854
Lilly USA, LLC59$613
Pfizer21$318
GSK22$289
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)16$270
Otsuka America Pharmaceutical, Inc.17$268
Astellas Pharma US Inc12$253
Antares Pharma, Inc.13$204
Takeda Pharmaceuticals U.S.A., Inc.12$175
Boehringer Ingelheim9$131
Sanofi-aventis U.S. LLC8$123
Exact Sciences7$120
Biohaven Pharmaceuticals, Inc.8$113
Kowa Pharmaceuticals America, Inc.8$112
Jazz Pharmaceuticals Inc.7$112
Idorsia Pharmaceuticals US Inc7$110
Lundbeck LLC7$109
Merck8$109
Abbott6$97
Bayer5$82
Daiichi Sankyo Inc.6$78
Intuity Medical Inc1$77
Axsome Therapeutics, Inc.4$67
Neurocrine Biosciences, Inc.4$58
Biohaven Pharmaceutical Holding Company Ltd.4$54
Nevro Corp.3$53
Phathom Pharmaceuticals, Inc.3$43
Phadia US Inc.2$42
Hologic Sales And Service, LLC2$36
Inspire Medical Systems, Inc.1$35
Eisai Inc.2$33
Bausch Health US, LLC2$33
Insulet Corporation2$29
Seqirus USA Inc2$27
IBSA Pharma Inc.2$25
Corium, LLC1$23
Kaleo, Inc.1$18
Soleno Therapeutics, Inc.1$17
Halozyme Inc1$17
Corcept Therapeutics1$15
Genentech USA, Inc.1$15
Adlon Therapeutics L.p.1$14
Amgen1$13
Amarin Pharma, Inc.1$13
Teva Pharmaceuticals USA, Inc.1$13
Esperion Therapeutics, Inc.1$13
Acerus Pharmaceuticals Corporation1$13
Medtronic1$12

How this compares

$9,316 in reported general payments places this provider in the 95th percentile of 573 medical providers in New Jersey.

See all medical providers in New Jersey →

Medicare billing

Part B allowed, 2024
$10,317
Medicare patients
75
Services billed
162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical in Flemington

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →